For the quarter ending 2026-03-31, TWST made $110,715K in revenue. -$44,089K in net income. Net profit margin of -39.82%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 110,715 | 103,698 | 99,009 | 96,057 |
| Cost of revenues | 53,593 | 49,726 | 48,172 | 44,760 |
| Research and development expenses | 19,695 | 17,130 | 17,014 | 18,047 |
| Selling, general and administrative expenses | 76,085 | 69,742 | 63,758 | 63,370 |
| Restructuring and other costs | - | - | 0* | - |
| Change in fair value of contingent considerations and holdbacks | - | - | 0* | - |
| Impairment of long-lived assets | - | - | 0* | 0 |
| Litigation settlement costs, net of recoveries | 7,205 | - | - | - |
| Total costs and expenses | 156,578 | 136,598 | 128,944 | 126,177 |
| Loss from operations | -45,863 | -32,900 | -29,935 | -30,120 |
| Loss on sale of business | - | - | 167 | 48,847 |
| Interest income | 1,710 | 2,175 | 2,633 | 2,690 |
| Other income (expense), net | 175 | 471 | 253 | -836 |
| Loss before income taxes | -43,978 | -30,254 | -26,882 | 20,581 |
| Income tax expense | 43 | 253 | 253 | 191 |
| Net loss | -44,021 | -30,507 | -27,138 | 20,390 |
| Change in unrealized loss (gain) on investments | -85 | 18 | 11 | -25 |
| Foreign currency translation adjustment | 17 | 38 | 208 | -177 |
| Comprehensive loss | -44,089 | -30,451 | -26,919 | 20,188 |
| Basic EPS | -0.71 | -0.5 | -0.445 | 0.34 |
| Diluted EPS | -0.71 | -0.5 | -0.454 | 0.33 |
| Basic Average Shares | 61,702,000 | 61,080,000 | 60,426,000 | 59,995,000 |
| Diluted Average Shares | 61,702,000 | 61,080,000 | 59,257,000 | 61,164,000 |
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)